The discussion at the fourth session was centered on the fusion of academic rigor and industrial pragmatism as a key to pioneering solutions for sustainable and prosperous future
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
Aurigene.AI is an end-to-end solution for small molecule drug discovery
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination
The new campus has been designed as an employee-centred experience and ecosystem zone
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Robots make it to the healthcare conference panel, reflecting the future potential of technology
Subscribe To Our Newsletter & Stay Updated
